Drugs / MK8141
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00543413 | Oct 2007 → Jun 2008 | hypertensive disorder | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK8141 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00543413 ↗ |
| Known as | ACT-077825 | “The renin inhibitor MK-8141 (ACT-077825) demonstrates substantial immunoreactive” PMID 20705534 ↗ Aug 2010 |
| Action | Inhibit | “The renin inhibitor MK-8141” PMID 20705534 ↗ Aug 2010 |